Compass Therapeutics, Inc. (CMPX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.61
- As of
Kresmion compiles this page from CMPX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Compass Therapeutics, Inc. (CMPX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-09.
See the full CMPX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CMPX on one page. Preview it with sample data, then open it live with a free account.
Preview the CMPX dossierActive events for CMPX
- mediumEarnings below estimates
Q3-2026: Missed consensus by 16.2%, EPS $-0.15 vs $-0.1291 estimate
- high13F: funds added
5 tracked funds increased CMPX this 2026Q2, institutional consensus
- high13F: large increase
CITADEL ADVISORS LLC added +3279% to CMPX (2026Q2)
- high13F: funds added
4 tracked funds increased CMPX this 2026Q2, institutional consensus
- medium13F: new position
Point72 Asset Management, L.P. new position in CMPX
FREE, NO ACCOUNT
Every event on CMPX, as it fires
You are seeing 5 of 11 events recorded on CMPX since 2026-06-09.
The five above landed across 3 days. The other 6 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, CMPX
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
More data on CMPX
CMPX against its peers
CMPX's return on equity of -33.8% ranks in the 64th percentile of 17 Biotechnology sub-industry peers, fiscal periods ending between 2025-10-31 and 2025-12-31.
| Metric | CMPX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 0.0 USD | 2.9M USD | 8 | 11 |
| Operating margin | n/a | -1536.9% | n/a | 11 |
| Net margin | n/a | -546.1% | n/a | 11 |
| Return on equity | -33.8% | -67.6% | 64 | 17 |
| 1 year | -86.5% | -36.1% | 13 | 18 |
Peers (22): MSLE, MGNX, MENS, NTHI, CNTN, ALXO, ARMP, YARW, PYPD, ABEO, LENZ, UPB, ENGN, HUMA, FATE, TARA, SPRB, FHTX, IPHA, SION, ORMP, ZURA. Left out: RNA (no annual filing), VRXA (no annual filing), SCNLD (no annual filing). Fiscal periods ending between 2025-10-31 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (CMPX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CMPX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CMPX in the last 180 days.
Upstream: SEC EDGAR filings for CMPX
Kresmion, "Compass Therapeutics, Inc. (CMPX) institutional holdings and SEC filings", data as of 2026-11-12, https://kresmion.com/research/CMPX. Upstream data: SEC EDGAR filings for CMPX.
Link to this data (HTML):
<a href="https://kresmion.com/research/CMPX">Compass Therapeutics, Inc. (CMPX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CMPX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CMPX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.